An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19

J Med Virol. 2020 Oct;92(10):1743-1744. doi: 10.1002/jmv.25826. Epub 2020 Apr 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Dopamine
  • Humans
  • Respiratory Insufficiency*
  • SARS-CoV-2

Substances

  • Dopamine